DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09

Sources: The Primary-Source Hierarchy Behind Every Figure

Every price in this database traces to a primary source: the provider's own published pricing page, read on the capture date shown, with an archive link preserved. This page describes the source hierarchy; each record's specific links live in the database and on its provider page.

Tier 1 — provider-published pricing pages (checkout pages, plan pages, published rate cards): the only tier that earns source-verified status. Tier 2 — company statements elsewhere (interviews, ads, press releases, marketplace listings): recorded with a stated-not-verified flag until the figure appears on Tier 1. Tier 3 — regulatory and manufacturer primary sources for context: FDA shortage-list determinations and compounding guidance, the April 2026 proposed rule, federal court rulings in the OFA litigation, Eli Lilly's LillyDirect pricing announcements, and Novo Nordisk's NovoCare pricing announcements. Never used as price sources: review aggregators, affiliate roundups, forums, or other comparison sites — the places circular citation is born. Archive links use the Internet Archive; where a provider blocks archiving, we retain dated captures and say so on the record.